bioRxiv Science⌕ Search

bioRxiv · 10.1101/2024.01.30.577980

A benchmark of computational methods for correcting biases of established and unknown origin in CRISPR-Cas9 screening data

Abstract

CRISPR-Cas9 dropout screens stand as formidable tools for investigating biology with unprecedented precision and scale. One of their principal applications involves probing large panels of immortalised human cancer cell lines for viability reduction responses upon systematic genetic knock-out at a genome-wide level, to identify novel cancer dependencies and therapeutic targets. However, biases in CRISPR-Cas9 screens data pose challenges, leading to potential confounding effects on their interpretation and compromising their overall quality. The mode of action of the Cas9 enzyme, exerted by the induction of DNA double-strand breaks at a locus targeted by a specifically designed single-guide RNA (sgRNA), is influenced by structural features of the target site, including copy number amplifications (CN bias). More worryingly, proximal targeted loci tend to generate similar gene-independent responses to CRISPR-Cas9 targeting (proximity bias), possibly due to Cas9-induced whole chromosome-arm truncations or other unknown genomic structural features and different chromatin accessibility levels. Different computational methods have been proposed to correct these biases in silico, each based on different modelling assumptions. We have benchmarked seven of the latest methods, rigorously evaluating for the first time their ability to reduce both CN and proximity bias in the two largest publicly available cell-line-based CRISPR-Cas9 screens to date. We have also evaluated the capability of each method to preserve data quality and heterogeneity by assessing the extent to which the processed data allows accurate detection of true positive essential genes, established oncogenetic addictions, and known/novel biomarkers of cancer dependency. Our analysis sheds light on the ability of each method to correct biases arising from structural properties and other possible unknown factors associated with CRISPR-Cas9 screen data under different scenarios. In particular, it shows that AC-Chronos outperforms other methods in correcting both CN and proximity biases when jointly processing multiple screens of models with available CN information, whereas CRISPRcleanR is the top performing method for individual screens or when CN information is not available for the screened models. In addition, Chronos and AC-Chronos yield a final dataset better able to recapitulate known sets of essential and non-essential genes. Overall, our investigation provides guidance for the selection of the most appropriate bias-correction method, based on its strengths, weaknesses and experimental settings.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Vinceti, A., Iannuzzi, R. M., Trastulla, L., Iorio, F.. 2024-01-31. A benchmark of computational methods for correcting biases of established and unknown origin in CRISPR-Cas9 screening data. https://doi.org/10.1101/2024.01.30.577980

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

mFrag: Integrating External DNA Methylation References Improves Lung Cancer Early Detection by Fragmentomics

Fragmentomics analyzes features of circulating cell-free DNA fragments (e.g., fragment length or end motifs) derived from whole-genome sequencing of liquid biopsy samples (blood or other body fluids), enabling non-invasive early cancer detection. Here we present mFrag, a framework that integrates external methylation reference atlases with fragmentomic features for lung cancer detection. mFrag comprises two complementary methods: mFrag-Weight, which uses DNA methylation information to weight fragmentomic features, and mFrag-Net, which integrates fragmentomic features and external DNA methylation data through neural networks. We average the output probabilities of the two methods to obtain a final prediction score. The mFrag model was trained using 287 individuals at risk for lung cancer. In an independent case-control testing set comprising 385 non-cancer controls and 46 cancers (28 stage I, 12 stage II, and 6 stage III or IV), mFrag outperforms a DELFI-style fragmentomic approach, improving PR-AUC from 0.455 to 0.720 and sensitivity at 99% specificity from 0.043 to 0.478, with ROC-AUC from 0.871 to 0.908. For stage I lung cancer, mFrag raises PR-AUC from 0.314 to 0.558 and ROC-AUC from 0.855 to 0.894. Applied to end 4-mer motif features, mFrag likewise improved over an unweighted baseline, with gains contributed by both mFrag-Weight and mFrag-Net. In summary, mFrag improves the accuracy of fragmentomics-based lung cancer detection through integrating external DNA methylation data and the complementarity of its two component models, without incurring any additional data-generating cost.

bioinformatics↗

AOPTK: Open-Source Software for AI-Assisted Toxicological Literature Analysis

Motivation: Toxicologists today face a challenge: although vast amounts of data describing how chemicals affect human health are available across scientific publications and regulatory reports, much of this information remains underutilized because extracting and interpreting evidence across thousands of studies is impractical to perform manually. Recent advances in artificial intelligence (AI), particularly in large language models (LLMs), provide new opportunities to automate toxicological literature analysis. Results: Herein, we present the Adverse Outcome Pathway Toolkit (AOPTK), an open-source Python package for AI-enhanced analysis of toxicological and biomedical literature. AOPTK supports (i) automated literature retrieval from databases such as PubMed Central and Europe PMC, (ii) direct processing of full-text articles in PDF format, and (iii) LLM-assisted analysis tools to identify chemicals and extract their relationships to biological effects under user-defined conditions. We demonstrate its utilities through a case-study identifying potential non-genotoxic carcinogens based on their ability to inhibit gap junction intercellular communication (GJIC). The LLM-enhanced analysis achieves 81% agreement with an expert-curated inhibitor list and 95% accuracy in predicting inhibition versus no inhibition when analysing the same subset of 86 publications. Automated retrieval and analysis of 1 124 publications from PubMed Central further demonstrated the feasibility of applying AOPTK to large-scale literature analyses. Availability: The package is developed open source on GitHub, disseminated through PyPI and Bioconda and releases are archived on Zenodo. Individual tools are available in the Galaxy platform for accessible data analysis with user-friendly, findable, accessible, interoperable, and reusable (FAIR) and end-to-end workflows provided via WorkflowHub. The tools are available on usegalaxy.eu and usegalaxy.cz and are developed open source on GitHub.

bioinformatics↗

MELD: Mutation Effect Learning through Differential embeddings

We introduce MELD (Mutation Effect Learning through Differential Embeddings), a compact model for predicting the functional consequences of single nucleotide variants (SNVs) by training directly on the wild-type (WT) versus mutant differential. Interpreting SNVs is central to clinical genomics, yet experimental characterization cannot scale to millions of observed variants. Leading sequence-to-function models (Enformer, Borzoi, AlphaGenome) are trained on absolute genomic tracks and score variants post hoc through in-silico mutagenesis (ISM), so the WT-mutant difference never enters the training loss. MELD instead places the logit difference {Delta}z = zmut - zwt inside the supervised objective. It combines a shared CNN-Transformer encoder, a mutant-specific mutation-mask boost, multiscale mutation-centered pooling, and a learned adaptive amplification factor . On ClinVar (1.57M variants), MELD (1.9M parameters) reached an AUROC of 0.986 versus 0.800 for a same-data, same-backbone ISM baseline, with ablations confirming the contribution of each component. On a shared benchmark, it outperformed frozen foundation models with 3-1,300x more parameters (AUROC 0.967 vs. 0.924 for AlphaGenome and 0.936 for Nucleotide Transformer). With only 50, 000 training variants, it exceeded the ISM baseline trained on all 1.48M (AUROC 0.903 vs. 0.796) variants. On BRCA1 saturation genome editing, frozen MELD achieved a Spearman {rho} of 0.42, above Borzoi (0.40), and ClinVar transfer raised it to 0.45. These results demonstrate that direct differential supervision is a compact, data-efficient alternative to post-hoc ISM scoring with substantially larger pretrained models.

bioinformatics↗